2211903-84-1 Usage
Description
1-(4-(tributylstannyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one is a complex organic chemical compound characterized by a benzophenone derivative with a tributylstannyl group substitution. It features a seven-membered nitrogen-containing ring and a carbonyl group, offering unique structural and property attributes that make it a compound of interest in the fields of organic chemistry and material science.
Uses
Used in Organic Chemistry:
1-(4-(tributylstannyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one is used as a reagent in organic chemistry for [application reason]. The tributylstannyl group, being a stannyl (tin) derivative, provides unique reactivity and synthetic utility in various chemical transformations.
Used in Material Science:
In the field of material science, 1-(4-(tributylstannyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one is used as a component in the development of novel materials for [application reason]. Its unique structure may contribute to the creation of materials with specific properties, such as improved stability, reactivity, or other desired characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 2211903-84-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,2,1,1,9,0 and 3 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2211903-84:
(9*2)+(8*2)+(7*1)+(6*1)+(5*9)+(4*0)+(3*3)+(2*8)+(1*4)=121
121 % 10 = 1
So 2211903-84-1 is a valid CAS Registry Number.
2211903-84-1Relevant articles and documents
Rapid Cu-Catalyzed [211At]Astatination and [125I]Iodination of Boronic Esters at Room Temperature
Reilly, Sean W.,Makvandi, Mehran,Xu, Kuiying,Mach, Robert H.
, p. 1752 - 1755 (2018)
Access to 211At- and 125I-radiolabeled compounds in excellent RCCs and RCYs was achieved in just 10 min at room temperature using a Cu catalyst. The reaction conditions are applicable to a broad class of aryl and heteroaryl boronic reagents with varying steric and electronic properties as well as late-stage astatination and iodination of anticancer PARP inhibitors. This protocol eliminates the traditional need for toxic organotin reagents, elevated temperatures, and extended reaction times, providing a more practical and environmentally friendly approach to developing α-emitting radiotherapeutics.
